Hwan Y. Yu
Mokdong, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Assessment of the Therapeutic Effectiveness of Glutathione-Enhanced Mesenchymal Stem Cells in Rat Models of Chronic Bladder Ischemia-Induced Overactive Bladder and Detrusor Underactivity.
Journal: International journal of stem cells
Published: September 03, 2023
Therapeutic effects of axitinib, an anti-angiogenic tyrosine kinase inhibitor, on interstitial cystitis.
Journal: Scientific reports
Published: January 30, 2023
Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I Study.
Journal: Stem cells translational medicine
Published: May 30, 2022
A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia.
Journal: Stem cell reviews and reports
Published: June 09, 2021
Small-sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft-versus-host disease.
Journal: Clinical and translational medicine
Published: March 24, 2021
Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndrome.
Journal: Biomaterials
Published: March 09, 2021
Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Multipotent Stem/Stromal Cells in Diabetic Detrusor Underactivity: A Preclinical Study.
Journal: Journal of clinical medicine
Published: August 16, 2020
Synergistic Effects of N-Acetylcysteine and Mesenchymal Stem Cell in a Lipopolysaccharide-Induced Interstitial Cystitis Rat Model.
Journal: Cells
Published: December 04, 2019
Current and Future Directions of Stem Cell Therapy for Bladder Dysfunction.
Journal: Stem cell reviews and reports
Published: November 24, 2019
Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway.
Journal: Science advances
Published: November 07, 2019
Ascorbic Acid 2-Glucoside Stably Promotes the Primitiveness of Embryonic and Mesenchymal Stem Cells Through Ten-Eleven Translocation- and cAMP-Responsive Element-Binding Protein-1-Dependent Mechanisms.
Journal: Antioxidants & redox signaling
Published: October 28, 2019
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.
Journal: EMBO molecular medicine
Published: May 13, 2019
Last Updated: 09/26/2026